Business

Business

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)

Ligand Pharmaceuticals Incorporated LGND and Channel Therapeutics Corporation CHRO on Thursday signed a definitive merger agreement to combine Ligand’s wholly

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO) Read Post »

Scroll to Top